{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:35:06Z","timestamp":1777700106639,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00296-017-3703-8","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T12:29:40Z","timestamp":1490012980000},"page":"785-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Abeer A.","family":"El-Henawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Abdel Razek","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nairmen","family":"Nabih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa M.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat","family":"Mashaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"3703_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356\u2013361","journal-title":"Nature"},{"key":"3703_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205\u20131213","journal-title":"Arthritis Rheum"},{"key":"3703_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219","journal-title":"N Engl J Med"},{"issue":"2","key":"3703_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00436-010-1899-6","volume":"107","author":"SMKDG SkariahMcIntyreMordue","year":"2010","unstructured":"Skariah S, McIntyre MK, Mordue DG (2010) Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol Res 107(2):253\u2013260","journal-title":"Parasitol Res"},{"key":"3703_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2334-9-76","volume":"9","author":"EG Fromont","year":"2009","unstructured":"Fromont EG, Riche B, Rabilloud M (2009) Toxoplasma seroprevalence in a rural population in France: detection of a household effect. BMC Infect Dis 9:76","journal-title":"BMC Infect Dis"},{"key":"3703_CR6","doi-asserted-by":"publisher","unstructured":"Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168e77.","DOI":"10.1016\/j.jaut.2009.11.018"},{"issue":"1\u20132","key":"3703_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jaut.2012.01.001","volume":"39","author":"Y Shapira","year":"2012","unstructured":"Shapira Y, Agmon-Levin N, Selmi C, Petr\u00edkov\u00e1 J, Barzilai O, Rama M et al (2012) Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun 39(1\u20132):112\u2013116","journal-title":"J Autoimmun"},{"key":"3703_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-013-8402-2","author":"S Fischer","year":"2013","unstructured":"Fischer S, Agmon-Levin N, Shapira Y, Katz BP, Graell E, Cervera R et al (2013) Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis. Immunol Res. doi:\n10.1007\/s12026-013-8402-2","journal-title":"Immunol Res"},{"issue":"10","key":"3703_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S2222-1808(16)61133-7","volume":"6","author":"NM El-Sayed","year":"2016","unstructured":"El-Sayed NM, Kishik SM, Fawzy RM (2016) The current status of Toxoplasma gondii infection among Egyptian rheumatoid arthritis patients. Asian Pac J Trop Dis 6(10):797\u2013801.","journal-title":"Asian Pac J Trop Dis"},{"issue":"5","key":"3703_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(5):625\u2013639","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9194","key":"3703_CR11","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"R Maini","year":"1999","unstructured":"Maini R, St Clair EW, Breedveld F, Frust D, Kalden J, Weisman M et al (1999) Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group. The Lancet 354(9194):1932\u20131939","journal-title":"The Lancet"},{"issue":"6","key":"3703_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","volume":"130","author":"LW Moreland","year":"1999","unstructured":"Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ et al (1999) Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130(6):478\u2013486","journal-title":"Ann Intern Med"},{"issue":"1","key":"3703_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA et al (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48(1):35\u201345","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3703_CR14","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1002\/art.20568","volume":"50","author":"EW St Clair","year":"2004","unstructured":"St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P et al (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50(11):3432\u20133443","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3703_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3858\/emm.2011.43.10.063","volume":"43","author":"H Shim","year":"2011","unstructured":"Shim H (2011) One target, different effects: a comparison of distinct therapeutic antibodies against the same targets. Exp Mol Med 43(10):539\u2013549","journal-title":"Exp Mol Med"},{"issue":"9","key":"3703_CR16","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"S5","key":"3703_CR17","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1002\/art.11407","volume":"49","author":"J Fransen","year":"2003","unstructured":"Fransen J, Stucki G, van Riel PLCM (2003) Rheumatoid arthritis measures: disease activity score (DAS), disease activity score-28 (DAS28), rapid assessment of disease activity in rheumatology (RADAR), and rheumatoid arthritis disease activity index (RADAI). Arthritis Rheum 49(S5):S214\u2013S224","journal-title":"Arthritis Rheum"},{"key":"3703_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gut.53.1.7","volume":"53","author":"JV Weinstock","year":"2004","unstructured":"Weinstock JV, Summers R, Elliot DE (2004) Helminths and harmony. Gut 53:7\u20139","journal-title":"Gut"},{"issue":"1","key":"3703_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pt.2007.10.006","volume":"24","author":"P Zaccone","year":"2007","unstructured":"Zaccone P, Oliver T, Burton OT, Cooke A (2007) Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol 24(1):35\u201342","journal-title":"Trends Parasitol"},{"key":"3703_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijpara.2008.08.007","volume":"39","author":"OsadaY","year":"2009","unstructured":"OsadaY, Shimizu S, KumagaiT, Yamada S, Kanazawa T (2009) Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int J Parasitol 39:457\u2013464","journal-title":"Int J Parasitol"},{"issue":"1","key":"3703_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/08916930802228290","volume":"42","author":"MC Salinas-Carmona","year":"2009","unstructured":"Salinas-Carmona MC, de la Cruz-Galicia G, P\u00e9rez-Rivera I, Sol\u00eds-Soto JM, Segoviano-Ramirez JC, V\u00e1zquez AV, Garza MA (2009) Spontaneous arthritis in MRL\/lpr mice is aggravated by Staphylococcus aureus and ameliorated by Nippostrongylus brasiliensis infections. Autoimmunity 42(1):25\u201332","journal-title":"Autoimmunity"},{"key":"3703_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0001-706X(01)00202-9","volume":"81","author":"DM Engman","year":"2002","unstructured":"Engman DM, Leon JS (2002) Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop 81:123\u2013132","journal-title":"Acta Trop"},{"key":"3703_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/0022-3859.30321","volume":"53","author":"M Sert","year":"2007","unstructured":"Sert M, Ozbek S, Paydas S, Yaman A (2007) Is there any relationship between Toxoplasma infection and reactive arthritis? J Postgrad Med 53:14\u201316","journal-title":"J Postgrad Med"},{"issue":"3","key":"3703_CR24","doi-asserted-by":"publisher","first-page":"e90203","DOI":"10.1371\/journal.pone.0090203","volume":"9","author":"J Flegr","year":"2014","unstructured":"Flegr J, Prandota J, Sovi\u010dkov\u00e1 M, Israili ZH (2014) Toxoplasmosis\u2014a global threat. Correlation of latent toxoplasmosis with specific disease burden in a Set of 88 Countries. PLoS One 9(3):e90203. doi:\n10.1371\/journal.pone.0090203","journal-title":"PLoS One"},{"key":"3703_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.184.2.597","volume":"184","author":"O Liesenfeld","year":"1996","unstructured":"Liesenfeld O, Kosek J, Remington JS, Suzuki Y (1996) Association of CD4 + T cell-dependent, IFN-g mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184:597\u2013607","journal-title":"J Exp Med"},{"key":"3703_CR26","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1086\/338006","volume":"185","author":"O Liesenfeld","year":"2002","unstructured":"Liesenfeld O (2002) Oral infection of C57BL\/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185:S96\u2013S101","journal-title":"J Infect Dis"},{"key":"3703_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1749-6632.2009.04673.x","volume":"1173","author":"M Lidar","year":"2009","unstructured":"Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N et al (2009) Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann NY Acad Sci 1173:640\u2013648","journal-title":"Ann NY Acad Sci"},{"key":"3703_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00417-009-1242-z","volume":"248","author":"JG Garweg","year":"2010","unstructured":"Garweg JG, De Kozak Y, Goldenberg B, Graefes MB (2010) Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis. Arch Clin Exp Ophthalmol 248:573\u2013584","journal-title":"Arch Clin Exp Ophthalmol"},{"key":"3703_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00436-009-1350-z","volume":"104","author":"HM Elsheikha","year":"2009","unstructured":"Elsheikha HM, Azab MS, Abousamra NK, Rahbar MH, Elghannam DM, Raafat D (2009) Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Parasitol Res 104:1471\u20131476","journal-title":"Parasitol Res"},{"issue":"6","key":"3703_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1645\/GE-2554.1","volume":"96","author":"YM Al-Kappany","year":"2010","unstructured":"Al-Kappany YM, Rajendran C, Ferreira LR, Kwok OCH, Abu-Elwafa SA, Hilali M, Dubey JP (2010) High prevalence of toxoplasmosis in cats from Egypt: isolation of viable Toxoplasma gondii, tissue distribution, and isolate designation. J Parasitol 96(6):1115\u20131118","journal-title":"J Parasitol"},{"issue":"6","key":"3703_CR31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3201\/eid1506.090101","volume":"15","author":"ID Xynos","year":"2009","unstructured":"Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV (2009) Leishmaniasis, autoimmune rheumatic aisease, and anti\u2013tumor necrosis factor therapy, Europe. Emerg Infect Dis 15(6):956\u2013959","journal-title":"Emerg Infect Dis"},{"issue":"14","key":"3703_CR32","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1056\/NEJMc051556","volume":"353","author":"JD Young","year":"2005","unstructured":"Young JD, McGwire BS (2005) Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med 353(14):1530\u20131531","journal-title":"N Engl J Med"},{"issue":"4","key":"3703_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semarthrit.2006.08.004","volume":"36","author":"S Lassoued","year":"2007","unstructured":"Lassoued S, Zabraniecki L, Marin F, Billey T (2007) Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin Arthritis Rheum 36(4):262\u2013263","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3703_CR34","first-page":"283","volume":"62","author":"VF Azevedo","year":"2010","unstructured":"Azevedo VF, Pietrovski CF, de Almeida Santos Jr M (2010) Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report. Reumatismo 62(4):283\u2013285","journal-title":"Reumatismo"},{"issue":"2","key":"3703_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/rheumatology\/ket364","volume":"53","author":"R Nardone","year":"2014","unstructured":"Nardone R, Zuccoli G, Brigo F, Trinka E, Golaszewski S (2014) Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis. Rheumatology (Oxford) 53(2):284","journal-title":"Rheumatology (Oxford)"},{"key":"3703_CR36","first-page":"40","volume":"5","author":"B Bouvard","year":"2016","unstructured":"36-Cren JB, Bouvard B, Crochette N (2016) Cerebral toxoplasmosis and anti-TNF-\u03b1: a case report. ID Cases 5:40\u201342.","journal-title":"ID Cases"},{"issue":"4","key":"3703_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/ard.53.4.224","volume":"53","author":"MJ Veen van der","year":"1994","unstructured":"van der Veen MJ, van der Heide A, Kruize AA, Bijlsma JW (1994) Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 53(4):224\u2013228","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3703_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.bdj.4811972","volume":"198","author":"GM Deeming","year":"2005","unstructured":"Deeming GM, Collingwood J, Pemberton MN (2005) Methotrexate and oral ulceration. Br Dent J 198(2):83\u201385","journal-title":"Br Dent J"},{"key":"3703_CR39","first-page":"1535","volume":"55","author":"RH Kuba","year":"2014","unstructured":"Kuba RH, Zghair KH, Alosami MH (2014) Detection of Toxoplasma antibodies and TNF-\u03b1 in rheumatoid arthritis patients treated with methotrexate. Iraqi J Sci 55:1535\u20131540","journal-title":"Iraqi J Sci"},{"issue":"supple 3","key":"3703_CR40","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1086\/429996","volume":"41","author":"RS Wallis","year":"2005","unstructured":"Wallis RS, Broder M, Wong J, Lee A, Hoq L (2005) Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 41(supple 3):S194\u2013S198","journal-title":"Clin Infect Dis"},{"key":"3703_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/187221307779815039","volume":"1","author":"\u00c9 Toussirot","year":"2007","unstructured":"Toussirot \u00c9, Streit G, Wendling D, Minjoz J, Fleming B, Cedex FB et al (2007) Infectious complications with anti-TNF-\u03b1 diseases. Recent Pat Inflamm Allergy Drug Discov 1:39\u201347","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"3703_CR42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s100670200136","volume":"21","author":"C Ustun","year":"2002","unstructured":"Ustun C, Kallab A, Loebl D, Jillela A, Majewski B, Mazzella F et al (2002) Rheumatoid arthritis and immune thrombocytopenia: a report of two cases. Clin Rheumatol 21:543\u2013544","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3703_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.rbr.2014.03.011","volume":"54","author":"P Toth","year":"2014","unstructured":"Toth P, Bernd R (2014) Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate\/leflunomide combination. Rev Bras Reumatol 54(2):152\u2013154","journal-title":"Rev Bras Reumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3703-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T14:10:08Z","timestamp":1492611008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3703-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3703"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3703-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}